Get started

Strata Oncology (United States)

Alternate name: Strata Oncology
ROR: 039tnn984
OpenAlex ID: I4405264897
Virus-positive Merkel Cell Carcinoma Is an Independent Prognostic Group with Distinct Predictive Biomarkers
2021 · Kelly L. Harms, Lili Zhao, et al. · Clinical Cancer Research · 96
Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer
2024 · Jeffrey J. Tosoian, Yuping Zhang, et al. · JAMA Oncology · 68
PDF
Hepatic kinome atlas: An in‐depth identification of kinase pathways in liver fibrosis of humans and rodents
2022 · Justin F. Creeden, Zachary A. Kipp, et al. · Hepatology · 49
Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial
2022 · A. S. Mansfield, Z. Wei, et al. · npj Precision Oncology · 42
PDF
Next-generation sequencing implicates oncogenic roles for p53 and JAK/STAT signaling in microcystic adnexal carcinomas
2019 · May P. Chan, Komal R. Plouffe, et al. · Modern Pathology · 41
A genomic survey of sarcomas on sun-exposed skin reveals distinctive candidate drivers and potentially targetable mutations
2020 · Timothy I. Miller, Nicholas A. Zoumberos, et al. · Human Pathology · 37
Real-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples
2021 · Scott A. Tomlins, Daniel H. Hovelson, et al. · JCO Precision Oncology · 36
Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions
2021 · Binsheng Gong, Dan Li, et al. · Genome biology · 35
PDF
Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit
2023 · Scott A. Tomlins, Nickolay A. Khazanov, et al. · Communications Medicine · 30
PDF
Development and Validation of StrataNGS, a Multiplex PCR, Semiconductor Sequencing-Based Comprehensive Genomic Profiling Test
2021 · Scott A. Tomlins, Daniel H. Hovelson, et al. · Journal of Molecular Diagnostics · 24
Deep oncopanel sequencing reveals within block position-dependent quality degradation in FFPE processed samples
2022 · SEQC2 Oncopanel Sequencing Working Group, Yifan Zhang, et al. · Genome biology · 20
PDF
Risk Classification for Interstitial Cystitis/Bladder Pain Syndrome Using Machine Learning Based Predictions
2024 · Laura E. Lamb, Joseph J. Janicki, et al. · Urology · 15
PDF
Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit
2023 · Benjamin J. Bulen, Nickolay A. Khazanov, et al. · Cancer Research Communications · 12
PDF
Rapid Decentralized Prostate Cancer Risk Stratification by Portable Liquid Biopsy Analysis within a Clinical Biosensor Validation Framework
2026 · Kevin M. Koo, Grant Phillips, et al. · Advanced Science · 6
Non-fusion mutations in endometrial stromal sarcomas: what is the potential impact on tumourigenesis through cell cycle dysregulation?
2020 · Snehal B Patel, Colin McCormack, et al. · Journal of Clinical Pathology · 6
Genomic and Immune Landscape of Non–Small Cell Lung Cancer Brain Metastases
2025 · Manlu Liu, Justin C. Jagodinsky, et al. · JCO Precision Oncology · 5
Evaluation of a predictive biomarker for antibody drug conjugates (ADCs).
2024 · Sachdev P. Thomas, Laurel A. Habel, et al. · Journal of Clinical Oncology · 4
Immune and Genomic Heterogeneity of MET-Altered Non–Small Cell Lung Cancer
2025 · Manlu Liu, Rachel L. Minne, et al. · JCO Precision Oncology · 2
Antibody drug conjugates treatment response score (ADC TRS) for sequencing trastuzuamb deruxtecan (T-DXd) and sacituzumab govitecan (SG) in advanced breast cancer (aBC).
2025 · Andi Cani, Scott A. Tomlins, et al. · Journal of Clinical Oncology · 2
PDF
A pathologist’s primer on implementing new standard-of-care molecular biomarker testing for precision prostate cancer management
2025 · Steven C Smith, John W Melson, et al. · American Journal of Clinical Pathology · 2
Abstract 2171: A multivariate biomarker predicts sacituzumab govitecan response in solid tumors
2023 · Nickolay A. Khazanov, Laura E. Lamb, et al. · Cancer Research · 2
A prospective study of minimal residual disease in urological cancers using circulating tumour DNA
2025 · Arnav Srivastava, Derrian Cooley, et al. · British Journal of Urology · 1
A Concordance Study among 26 NGS Laboratories Participating in the NCI Molecular Analysis for Therapy Choice Clinical Trial
2025 · Linda K. Zane, Laura M. Yee, et al. · Clinical Cancer Research · 1
Hepatic adenomas in males: Is molecular characterization helpful in guiding its management?
2025 · Ekta Jain, Sarah A. Anderson, et al. · Human Pathology · 1
Abstract 2038: Antibody Drug Conjugates Treatment Response Score (ADC TRS) for predicting ADC treatment response
2025 · Sachdev P. Thomas, Laurel A. Habel, et al. · Cancer Research · 1
Works count: 61
Citation count: 2,543
Year
Topic
Type